Four New IPOs for the Week of July 20

Francis Gaskins |

dogprod.pngFull IPO Calendar & Reports HERE

Ranked by IPO Size

(1) Based in Wilton, CT, Blue Buffalo Pet Products (BUFF) scheduled a $502 million IPO on Nasdaq with a market capitalization of $3.3 billion at a price range midpoint of $17 for Wednesday, July 22, 2015.

BUFF is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients.

BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment and is one of the top pet food brands overall.

Started in 2003, BUFF currently has approximately 6% share of the overall pet food industry and feeds only 2-3% of the 164 million pets in the United States.

(2) Based in New York, NY, ETRE REIT (ESSF) scheduled a $173 million IPO on Nasdaq with a market capitalization of $173 million at a price range midpoint of $15 for the week of July 20, 2015.



ESSF is a newly organized Delaware series limited liability company that has been formed to permit public investment in individual commercial real estate properties, each of which will be held by a separate property-owning subsidiary owned by a separate series of limited liability company interests, or Series, that ESSF intends to establish. 

ESSF will acquire an indirect 48.87% interest in State Street Financial Center, a 36-story office tower, also known as One Lincoln Street, located in Boston, Massachusetts.

(3) Based in Wilmington, NC, Live Oak Bancshares (LOB) scheduled a $68 million IPO on Nasdaq with a market capitalization of $555 million at a price range midpoint of $17 for the week of July 20, 2015.

LOB is an established national online platform for small business lending.

LOB believes it has used technology to fundamentally change small business lending by streamlining the borrower experience. LOB is able to better serve its customers by leveraging technological advantages and combining that with deep industry experience to create an optimized borrowing experience for its customers.

(4) Based in Grand Prairie, TX, Neos Therapeutics (NEOS) scheduled a $60 million IPO on Nasdaq with a market capitalization of $205 million at a price range midpoint of $15 for Thursday, July 23, 2015.

NEOS is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platform, which NEOS has already used to develop its three branded product candidates for the treatment of attention deficit hyperactivity disorder, or ADHD.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…